Category: MIL-OSI

Posted on

Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026

Source: Resmed Inc

  • Revenue increased by 11% to $1.4 billion; up 9% on a constant currency basis 
  • Gross margin up 320 bps to 61.8%; non-GAAP gross margin up 310 bps to 62.3%
  • Income from operations increased 18%; non-GAAP income from operations up 19%
  • Diluted earnings per share of $2.68; non-GAAP diluted earnings per share of $2.81
  • Operating cash flow of $340 million

Note: A webcast of Resmed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com

SAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE) — Resmed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended December 31, 2025.

“Our second quarter results demonstrate the strength and resilience of our global business as we continue advancing our mission to help people sleep better, breathe better, and live longer and healthier lives in the comfort of their own home,” said Resmed’s Chairman and CEO, Mick Farrell.

“Year-over-year, we delivered 11% headline revenue growth, 310 basis points of non‑GAAP gross margin expansion, and continued operating excellence, resulting in another quarter of mid-teens non‑GAAP EPS growth. These results reflect strong ongoing demand for our market‑leading sleep and respiratory care devices, as well as the growing impact of our digital health ecosystem that spans more than 140 countries.

As we move into the second half of fiscal year 2026, we will continue to invest in innovation to scale our digital health capabilities and expand global access to life-saving care, while delivering sustainable, profitable growth.”

Financial Results and Operating Metrics

Unaudited; $ in millions, except for per share amounts

  Three Months Ended
  December 31,
2025		   December 31,
2024		   % Change   Constant
Currency(A)
Revenue $ 1,422.8     $ 1,282.1     11 %   9 %
Gross margin   61.8 %     58.6 %   5      
Non-GAAP gross margin(B)   62.3 %     59.2 %   5      
Selling, general, and administrative expenses   278.4       241.6     15     12  
Research and development expenses   91.0       81.4     12     10  
Income from operations   491.7       417.2     18      
Non-GAAP income from operations(B)   517.2       435.9     19      
Net income   392.6       344.6     14      
Non-GAAP net income(B)   411.5       358.3     15      
Diluted earnings per share $ 2.68     $ 2.34     15      
Non-GAAP diluted earnings per share(B) $ 2.81     $ 2.43     16      
  Six Months Ended
  December 31,
2025		   December 31,
2024		   % Change   Constant
Currency(A)
Revenue $ 2,758.4     $ 2,506.6     10 %   8 %
Gross margin   61.6 %     58.6 %   5      
Non-GAAP gross margin(B)   62.2 %     59.2 %   5      
Selling, general, and administrative expenses   537.6       480.6     12     10  
Research and development expenses   178.3       160.9     11     10  
Income from operations   938.2       804.6     17      
Non-GAAP income from operations(B)   999.3       842.3     19      
Net income   741.1       656.0     13      
Non-GAAP net income(B)   786.4       683.7     15      
Diluted earnings per share $ 5.05     $ 4.45     13      
Non-GAAP diluted earnings per share(B) $ 5.36     $ 4.63     16      
(A) In order to provide a framework for assessing how our underlying businesses performed, excluding the effect of foreign currency fluctuations, we provide certain financial information on a “constant currency” basis, which is in addition to the actual financial information presented. In order to calculate our constant currency information, we translate the current period financial information using the foreign currency exchange rates that were in effect during the previous comparable period. However, constant currency measures should not be considered in isolation or as an alternative to U.S. dollar measures that reflect current period exchange rates, or to other financial measures calculated and presented in accordance with U.S. GAAP.
   
(B) See the reconciliation of non-GAAP financial measures in the table at the end of the press release.
   

Discussion of Second Quarter Results
All comparisons are to the prior year period unless otherwise noted

  • Revenue grew by 9 percent on a constant currency basis, driven by increased demand for our portfolio of sleep devices, masks and accessories.
    • Revenue in the U.S., Canada, and Latin America, excluding Residential Care Software, grew by 11 percent.
    • Revenue in Europe, Asia, and other markets, excluding Residential Care Software, grew by 6 percent on a constant currency basis.
    • Residential Care Software revenue increased by 5 percent on a constant currency basis.
  • Gross margin increased by 320 basis points primarily driven by manufacturing and logistics efficiencies and component cost improvements. Non-GAAP gross margin increased by 310 basis points due to the same factors.
  • Selling, general, and administrative expenses increased by 12 percent on a constant currency basis. The increase in SG&A expenses was mainly due to additional expenses associated with our VirtuOx acquisition, employee costs as well as marketing and technology investments. SG&A expenses were 19.6 percent of revenue in the quarter, compared with 18.8 percent in the same period of the prior year.
  • We recorded $6 million of restructuring-related charges following the finalization of our company-wide workforce planning activities undertaken in the first quarter of the fiscal year. Restructuring charges were comprised of employee severance and other one-time termination benefits.
  • Income from operations increased by 18 percent and non-GAAP income from operations increased by 19 percent.
  • Net income for the quarter was $393 million and diluted earnings per share was $2.68. Non-GAAP net income increased by 15 percent to $411 million, and non-GAAP diluted earnings per share increased by 16 percent to $2.81, predominantly attributable to strong sales growth and gross margin improvement.
  • Operating cash flow for the quarter was $340 million, compared to net income in the current quarter of $393 million and non-GAAP net income of $411 million.
  • During the quarter, we paid $88 million in dividends to shareholders and repurchased 704,000 shares for consideration of $175 million as part of our ongoing capital management.

Other Business and Operational Highlights

  • Published new research in SLEEP (N=370,000+) showing in patients with OSA across all comorbidity cohorts each additional hour of PAP use linked to a 4.1-6.2% reduction in healthcare utilization over 12-24 months (p < 0.0001).
  • Announced it received FDA clearance for an AI-enabled digital medical device, to be marketed as Smart Comfort, designed to personalize CPAP comfort settings and improve patient adherence.
  • Presented at the J.P. Morgan Healthcare Conference, highlighting its long-term growth opportunities, connected-care ecosystem, and continued leadership in digital sleep and respiratory health.

Dividend program
The Resmed board of directors today declared a quarterly cash dividend of $0.60 per share. The dividend will have a record date of February 12, 2026, payable on March 19, 2026. The dividend will be paid in U.S. currency to holders of Resmed’s common stock trading on the New York Stock Exchange. Holders of CHESS Depositary Interests (“CDIs”) trading on the Australian Securities Exchange will receive an equivalent amount in Australian currency, based on the exchange rate on the record date, and reflecting the 10:1 ratio between CDIs and NYSE shares. The ex-dividend date will be February 11, 2026, for common stockholders and for CDI holders. Resmed has received a waiver from the ASX’s settlement operating rules, which will allow Resmed to defer processing conversions between its common stock and CDI registers from February 11, 2026, through February 12, 2026, inclusive. 

Webcast details
Resmed will discuss its second quarter fiscal year 2026 results on its webcast at 1:30 p.m. U.S. Pacific Time today. The live webcast of the call can be accessed on Resmed’s Investor Relations website at investor.resmed.com. Please go to this section of the website and click on the icon for the “Q2 2026 Earnings Webcast” to register and listen to the live webcast. A replay of the earnings webcast will be accessible on the website and available approximately two hours after the live webcast. In addition, a telephone replay of the conference call will be available approximately three hours after the webcast by dialing +1 877-660-6853 (U.S.) or +1 201-612-7415 (outside U.S.) and entering the passcode 13757750. The telephone replay will be available until February 12, 2026.

About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.

Safe harbor statement
Statements contained in this release that are not historical facts are “forward-looking” statements as contemplated by the Private Securities Litigation Reform Act of 1995. These forward-looking statements – including statements regarding Resmed’s projections of future revenue or earnings, expenses, new product development, new product launches, new markets for its products, the integration of acquisitions, our supply chain, domestic and international regulatory developments, litigation, tax outlook, and the expected impact of macroeconomic conditions of our business – are subject to risks and uncertainties, which could cause actual results to materially differ from those projected or implied in the forward-looking statements. Additional risks and uncertainties are discussed in Resmed’s periodic reports on file with the U.S. Securities & Exchange Commission. Resmed does not undertake to update its forward-looking statements.

Condensed Consolidated Statements of Operations
(Unaudited; $ in thousands, except for per share amounts)

  Three Months Ended   Six Months Ended
  December 31,
2025		   December 31,
2024		   December 31,
2025		   December 31,
2024
               
Net revenue $ 1,422,808     $ 1,282,089     $ 2,758,390     $ 2,506,598  
               
Cost of sales   536,276       523,180       1,043,217       1,022,800  
Amortization of acquired intangibles(1)   7,808       7,634       15,630       15,304  
Total cost of sales $ 544,084     $ 530,814     $ 1,058,847     $ 1,038,104  
Gross profit $ 878,724     $ 751,275     $ 1,699,543     $ 1,468,494  
               
Selling, general, and administrative   278,396       241,613       537,590       480,592  
Research and development   90,969       81,372       178,292       160,897  
Amortization of acquired intangibles(1)   11,764       11,047       23,721       22,451  
Restructuring expenses(1)   5,935       —       21,745       —  
Total operating expenses $ 387,064     $ 334,032     $ 761,348     $ 663,940  
Income from operations $ 491,660     $ 417,243     $ 938,195     $ 804,554  
               
Other income (expenses), net:              
Interest (expense) income, net $ 7,949     $ (775 )   $ 16,742     $ (2,436 )
Gain (loss) attributable to equity method investments   1,515       1,077       3,004       2,040  
Gain (loss) on equity investments   306       (1,439 )     (5,884 )     (2,119 )
Other, net   (5,282 )     2,216       (9,117 )     (219 )
Total other income (expenses), net   4,488       1,079       4,745       (2,734 )
Income before income taxes $ 496,148     $ 418,322     $ 942,940     $ 801,820  
Income taxes   103,555       73,700       201,811       145,843  
Net income $ 392,593     $ 344,622     $ 741,129     $ 655,977  
               
Basic earnings per share $ 2.69     $ 2.35     $ 5.08     $ 4.47  
Diluted earnings per share $ 2.68     $ 2.34     $ 5.05     $ 4.45  
Non-GAAP diluted earnings per share(1) $ 2.81     $ 2.43     $ 5.36     $ 4.63  
               
Basic shares outstanding   145,842       146,810       146,012       146,835  
Diluted shares outstanding   146,372       147,481       146,633       147,520  
                               
(1) See the reconciliation of non-GAAP financial measures in the table at the end of the press release.
 


Condensed Consolidated Balance Sheets
(Unaudited; $ in thousands)

  December 31,
2025		   June 30,
2025
Assets      
Current assets:      
Cash and cash equivalents $ 1,417,069     $ 1,209,450  
Accounts receivable, net   985,634       939,492  
Inventories   922,045       927,711  
Prepayments and other current assets   494,053       428,952  
Total current assets $ 3,818,801     $ 3,505,605  
Non-current assets:      
Property, plant, and equipment, net $ 564,254     $ 550,790  
Operating lease right-of-use assets   165,916       167,497  
Goodwill and other intangibles, net   3,474,610       3,511,541  
Deferred income taxes and other non-current assets   479,789       438,958  
Total non-current assets $ 4,684,569     $ 4,668,786  
Total assets $ 8,503,370     $ 8,174,391  
Liabilities and Stockholders’ Equity      
Current liabilities:      
Accounts payable $ 250,406     $ 278,157  
Accrued expenses   391,500       402,253  
Operating lease liabilities, current   29,759       30,506  
Deferred revenue   176,050       166,030  
Income taxes payable   140,493       132,274  
Short-term debt   259,906       9,900  
Total current liabilities $ 1,248,114     $ 1,019,120  
Non-current liabilities:      
Deferred revenue $ 159,789     $ 156,803  
Deferred income taxes   77,994       77,682  
Operating lease liabilities, non-current   154,133       153,015  
Other long-term liabilities   138,538       141,520  
Long-term debt   403,923       658,392  
Total non-current liabilities $ 934,377     $ 1,187,412  
Total liabilities $ 2,182,491     $ 2,206,532  
Stockholders’ equity      
Common stock $ 763     $ 761  
Additional paid-in capital   2,102,992       2,033,599  
Retained earnings   6,647,285       6,081,490  
Treasury stock   (2,400,298 )     (2,073,292 )
Accumulated other comprehensive income   (29,863 )     (74,699 )
Total stockholders’ equity $ 6,320,879     $ 5,967,859  
Total liabilities and stockholders’ equity $ 8,503,370     $ 8,174,391  
               


Condensed Consolidated Statements of Cash Flows
(Unaudited; $ in thousands)

  Three Months Ended   Six Months Ended
  December 31,
2025		   December 31,
2024		   December 31,
2025		   December 31,
2024
Cash flows from operating activities:              
Net income $ 392,593     $ 344,622     $ 741,129     $ 655,977  
Adjustment to reconcile net income to cash provided by operating activities:              
Depreciation and amortization   49,885       46,439       97,583       91,169  
Amortization of right-of-use assets   12,445       9,463       22,416       18,443  
Stock-based compensation costs   28,938       22,634       50,098       42,790  
(Gain) loss attributable to equity method investments, net of dividends received   (1,515 )     (1,077 )     (3,004 )     (2,040 )
(Gain) loss on equity investments   (306 )     1,439       5,884       2,119  
Changes in operating assets and liabilities:              
Accounts receivable, net   (72,682 )     (67,853 )     (42,712 )     (31,436 )
Inventories, net   26,129       (7,641 )     11,466       (77,895 )
Prepaid expenses, net deferred income taxes and other current assets   (106,387 )     (43,623 )     (104,075 )     (43,746 )
Accounts payable, accrued expenses, income taxes payable and other   10,645       4,219       18,281       (21,220 )
Net cash provided by (used in) operating activities $ 339,745     $ 308,622     $ 797,066     $ 634,161  
Cash flows from investing activities:              
Purchases of property, plant, and equipment   (28,539 )     (20,644 )     (71,504 )     (38,484 )
Patent registration and acquisition costs   (4,537 )     (2,825 )     (7,351 )     (4,592 )
Purchases of intangible assets   (1,479 )     —       (1,479 )     —  
Business acquisitions, net of cash acquired   —       (670 )     (522 )     (670 )
Purchases of investments   (4,231 )     (1,000 )     (6,404 )     (2,350 )
Proceeds from exits of investments   250       250       250       4,378  
Proceeds (payments) on maturity of foreign currency contracts   (12,406 )     (11,803 )     (16,510 )     7,172  
Net cash provided by (used in) investing activities $ (50,942 )   $ (36,692 )   $ (103,520 )   $ (34,546 )
Cash flows from financing activities:              
Proceeds from issuance of common stock, net   29,557       26,877       37,762       35,260  
Purchases of treasury stock   (175,014 )     (74,986 )     (325,024 )     (124,991 )
Taxes paid related to net share settlement of equity awards   (20,308 )     (16,734 )     (21,027 )     (17,123 )
Payments of business combination contingent consideration   —       —       —       (855 )
Repayment of borrowings   (5,000 )     (5,000 )     (5,000 )     (35,000 )
Dividends paid   (87,584 )     (77,695 )     (175,334 )     (155,586 )
Net cash provided by (used in) financing activities $ (258,349 )   $ (147,538 )   $ (488,623 )   $ (298,295 )
Effect of exchange rate changes on cash $ 2,767     $ (28,809 )   $ 2,696     $ (17,737 )
Net increase (decrease) in cash and cash equivalents   33,221       95,583       207,619       283,583  
Cash and cash equivalents at beginning of period   1,383,848       426,361       1,209,450       238,361  
Cash and cash equivalents at end of period $ 1,417,069     $ 521,944     $ 1,417,069     $ 521,944  
                               


Reconciliation of Non-GAAP Financial Measures
(Unaudited; $ in thousands, except for per share amounts)

The measures “non-GAAP gross profit” and “non-GAAP gross margin” exclude amortization expense from acquired intangibles and are reconciled below:

  Three Months Ended   Six Months Ended
  December 31, 2025   December 31, 2024   December 31, 2025   December 31, 2024
               
Revenue $ 1,422,808     $ 1,282,089     $ 2,758,390     $ 2,506,598  
               
GAAP cost of sales $ 544,084     $ 530,814     $ 1,058,847     $ 1,038,104  
Less:Amortization of acquired intangibles(A)   (7,808 )     (7,634 )     (15,630 )     (15,304 )
Non-GAAP cost of sales $ 536,276     $ 523,180     $ 1,043,217     $ 1,022,800  
               
GAAP gross profit $ 878,724     $ 751,275     $ 1,699,543     $ 1,468,494  
GAAP gross margin   61.8 %     58.6 %     61.6 %     58.6 %
Non-GAAP gross profit $ 886,532     $ 758,909     $ 1,715,173     $ 1,483,798  
Non-GAAP gross margin   62.3 %     59.2 %     62.2 %     59.2 %
                               

The measure “non-GAAP income from operations” is reconciled with GAAP income from operations below:

  Three Months Ended   Six Months Ended
  December 31, 2025   December 31, 2024   December 31, 2025   December 31, 2024
               
GAAP income from operations $ 491,660   $ 417,243   $ 938,195   $ 804,554
Amortization of acquired intangibles—cost of sales(A)   7,808     7,634     15,630     15,304
Amortization of acquired intangibles—operating expenses(A)   11,764     11,047     23,721     22,451
Restructuring(A)   5,935     —     21,745     —
Non-GAAP income from operations $ 517,167   $ 435,924   $ 999,291   $ 842,309
                       


Reconciliation of Non-GAAP Financial Measures
(Unaudited; $ in thousands, except for per share amounts)

The measures “non-GAAP net income” and “non-GAAP diluted earnings per share” are reconciled with GAAP net income and GAAP diluted earnings per share in the table below:

  Three Months Ended   Six Months Ended
  December 31, 2025   December 31, 2024   December 31, 2025   December 31, 2024
               
GAAP net income $ 392,593     $ 344,622     $ 741,129     $ 655,977  
Amortization of acquired intangibles—cost of sales(A)   7,808       7,634       15,630       15,304  
Amortization of acquired intangibles—operating expenses(A)   11,764       11,047       23,721       22,451  
Restructuring expenses(A)   5,935       —       21,745       —  
Income tax effect on non-GAAP adjustments(A)   (6,627 )     (4,962 )     (15,875 )     (10,033 )
Non-GAAP net income(A) $ 411,473     $ 358,341     $ 786,350     $ 683,699  
               
GAAP diluted shares outstanding   146,372       147,481       146,633       147,520  
GAAP diluted earnings per share $ 2.68     $ 2.34     $ 5.05     $ 4.45  
Non-GAAP diluted earnings per share(A) $ 2.81     $ 2.43     $ 5.36     $ 4.63  
(A) Resmed adjusts for the impact of the amortization of acquired intangibles and restructuring expenses from their evaluation of ongoing operations, and believes that investors benefit from adjusting these items to facilitate a more meaningful evaluation of current operating performance.

Resmed believes that non-GAAP diluted earnings per share is an additional measure of performance that investors can use to compare operating results between reporting periods. Resmed uses non-GAAP information internally in planning, forecasting, and evaluating the results of operations in the current period and in comparing it to past periods. Resmed believes this information provides investors better insight when evaluating Resmed’s performance from core operations and provides consistent financial reporting. The use of non-GAAP measures is intended to supplement, and not to replace, the presentation of net income and other GAAP measures. Like all non-GAAP measures, non-GAAP earnings are subject to inherent limitations because they do not include all the expenses that must be included under GAAP.
   


Revenue by Product and Region
(Unaudited; $ in millions, except for per share amounts)

  Three Months Ended
  December 31,
2025		 (A) December 31,
2024		 (A) % Change   Constant
Currency(B)
U.S., Canada, and Latin America              
Devices $ 448.0   $ 414.5   8 %    
Masks and other   387.0     334.5   16      
Total U.S., Canada and Latin America $ 835.0   $ 748.9   11      
               
Combined Europe, Asia, and other markets              
Devices $ 278.2   $ 254.8   9 %   5 %
Masks and other   142.7     121.8   17     8  
Total Combined Europe, Asia and other markets $ 420.9   $ 376.6   12     6  
               
Global revenue              
Total Devices $ 726.2   $ 669.3   9 %   7 %
Total Masks and other   529.7     456.3   16     14  
TotalSleep and Breathing Health $ 1,255.9   $ 1,125.6   12     10  
               
Residential Care Software   166.9     156.5   7     5  
Total $ 1,422.8   $ 1,282.1   11     9  
               
  Six Months Ended
  December 31,
2025		 (A) December 31,
2024		 (A) %
Change		   Constant
Currency(B)
U.S., Canada, and Latin America              
Devices $ 861.5   $ 799.0   8 %    
Masks and other   748.3     657.3   14      
Total U.S., Canada and Latin America $ 1,609.8   $ 1,456.3   11      
               
Combined Europe, Asia, and other markets              
Devices $ 545.0   $ 496.1   10 %   6 %
Masks and other   270.6     241.0   12     6  
Total Combined Europe, Asia and other markets $ 815.6   $ 737.1   11     6  
               
Global revenue              
Total Devices $ 1,406.5   $ 1,295.1   9 %   7 %
Total Masks and other   1,018.9     898.2   13     12  
TotalSleep and Breathing Health $ 2,425.4   $ 2,193.3   11     9  
               
Residential Care Software   333.0     313.3   6     5  
Total $ 2,758.4   $ 2,506.6   10     8  
(A) Totals and subtotals may not add due to rounding.
   
(B) In order to provide a framework for assessing how our underlying businesses performed excluding the effect of foreign currency fluctuations, we provide certain financial information on a “constant currency basis,” which is in addition to the actual financial information presented. In order to calculate our constant currency information, we translate the current period financial information using the foreign currency exchange rates that were in effect during the previous comparable period. However, constant currency measures should not be considered in isolation or as an alternative to U.S. dollar measures that reflect current period exchange rates, or to other financial measures calculated and presented in accordance with U.S. GAAP.
   

Source: Resmed, Inc.

Released January 29, 2026

Posted on

Woman charged following assault of baby

Source: ACT Police

Last update: Thursday, 29 January 2026 9:09am

Original publication: Thursday, 29 January 2026 9:08am

ACT Policing has charged a 56-year-old woman following the alleged assault of a four-week-old baby in Braddon on the weekend.

About 4.30pm on Saturday (24 January 2026) , a mother was walking with her four-week-old child in a pram on Ijong Street in Braddon when they were approached by another woman.

The other woman allegedly blocked the path before reaching into the pram, grabbing the child and flinging him to the ground. The mother took the baby to hospital for medical treatment and the matter was reported to police.

Yesterday, a 56-year-old woman was taken into custody and officers from the Sexual Assault and Child Abuse Team charged her with one count of recklessly inflicting grievous bodily harm. She is expected to face the ACT Magistrates Court today (Thursday, 29 January 2026).

Police are also investigating a second incident near Ijong Street in Braddon where a woman was allegedly assaulted immediately prior to this incident.

Witnesses to either incident are being sought by police.

Anyone who can assist the investigation is urged to contact Crime Stoppers via the Crime Stoppers ACT website. Please quote 8284796.

Posted on

Seeking to identify man following assaults and car damage in Gungahlin

Source: ACT Police

Last update: Wednesday, 28 January 2026 2:49pm

Original publication: Wednesday, 28 January 2026 2:49pm

ACT Policing is seeking to identify witnesses and a man who allegedly assaulted several members of the public in Gungahlin last weekend.

About 6:40pm on Saturday (24 January 2026), police received reports of a man allegedly assaulting members of the public and causing damage to cars in Hibberson Street in Gungahlin.

Following a review of CCTV footage, police are now seeking the public’s assistance to identify the man. He is described as Caucasian in appearance, and was wearing no shirt, khaki coloured shorts and black work boots at the time of the incidents. He was also carrying a black shirt with green writing on it and at one point, a plank of wood.

If you can identify the man, or may have witnessed the incidents, please contact Crime Stoppers via the Crime Stoppers ACT website. Please quote 8284259. Information can be provided anonymously.

Posted on

Police seeking information about Braddon bar assault

Source: ACT Police

Last update: Tuesday, 27 January 2026 3:32pm

Original publication: Tuesday, 27 January 2026 3:32pm

ACT Policing is seeking witnesses and information following an assault in a Braddon bar last month.

About 2:20am on Sunday, 7 December (2025), a man allegedly assaulted another man inside a licenced premises on Lonsdale Street in Braddon before fleeing the venue.

The alleged offender was accompanied by a woman, who left the licenced premises shortly after.

The man is described as Caucasian in appearance with short hair and was wearing a dark shirt that ripped during the incident, long pants and Nike branded sneakers. The man then took off his shirt and ran north along Lonsdale Street following the alleged assault.

The woman was wearing a white t-shirt and black leggings.

Police believe the man and woman depicted in the video were involved in the incident and would like to speak to them.

Anyone who has any information about this incident or who can identify the man or woman, is urged to contact Crime Stoppers via the Crime Stoppers ACT website or on 1800 333 000. Please quote 8204059.  Information can be provided anonymously.

Posted on

Man charged following attempted knifepoint carjacking

Source: ACT Police

Last update: Tuesday, 27 January 2026 8:33am

Original publication: Tuesday, 27 January 2026 8:33am

A 24-year-old Latham man who was subject to bail and good behaviour orders, has been charged with multiple offences following an alleged attempted carjacking incident in Melba yesterday.

About 2.15pm yesterday (Monday, 26 January 2026) police were called to Kingsford Smith Drive in Melba following reports of a man brandishing a large knife. After a short foot pursuit, the man dropped the knife he was carrying and was arrested.

Officers subsequently spoke to multiple witnesses who alleged the man had previously attempted to steal a vehicle by threatening a driver at knifepoint, however he failed to do so as he couldn’t start the vehicle.

The man was charged with breach of bail, breach of a good behaviour order, possession of stolen property, possess offensive weapon with intent, attempted aggravated robbery, property damage and intentional threat to inflict grievous bodily harm. He is expected to appear in the ACT Magistrates Court today (Tuesday, 27 January 2026).

Anyone who witnessed yesterday’s incident and has not already spoken to police is urged to contact Crime Stoppers on 1800 333 000, or via the Crime Stoppers ACT website.  Please quote 8285807. Information can be provided anonymously.

Posted on

Man charged following alleged assaults with a hammer

Source: ACT Police

Last update: Monday, 26 January 2026 10:19am

Original publication: Monday, 26 January 2026 10:04am

A 28-year-old man will face court today charged with assault after allegedly striking two people on the head with a hammer in the city overnight.

About 12:30am this morning (Monday, 26 January 2026), the man approached a group of people on City Walk and became involved in a verbal altercation with several individuals.

He then engaged in a physical altercation with another man, during which it is alleged he removed a hammer from his jumper pocket and struck a second man and a woman on the head before fleeing the scene.

The second man and the woman were transported to hospital with serious injuries.

About 1am, police located the man on Alinga Street in the City. He was arrested and taken to the ACT Watch House, where it is further alleged the man attempted to destroy evidence.

The 28-year-old man –who was also subject to court ordered good behaviour obligations in the ACT – has been charged with two counts of intentionally inflicting grievous bodily harm and obstructing/hindering an investigation. He is expected to face the ACT Magistrates Court today (Monday, 26 January 2026).

Posted on

Protest activity expected on Australia Day

Source: ACT Police

Last update: Monday, 26 January 2026 8:15am

Original publication: Monday, 26 January 2026 8:15am

ACT Policing is alerting the Canberra community to planned protest activity in the city and Parliamentary Precinct on Australia Day.

A planned protest march is expected from 10am today, beginning in the City before moving along the Commonwealth Avenue Bridge to Parliament House before finishing out the front of Old Parliament House.

Commonwealth Avenue will be closed to traffic for a short period while the group moves through the area.

Another planned protest march is expected at midday, beginning at Parliament House before finishing at Lennox Gardens in Yarralumla.

Minor traffic disruptions may occur as the marches move through the city and Parliamentary Precinct. Drivers are asked to consider their route if they do not want to be delayed when driving nearby.

ACT Policing supports the right of people to peacefully protest, however the disruption of business activity or other criminal activity will not be tolerated.

Traffic disruption updates will be provided when required via ACT Policing social media accounts.

Posted on

ONE TREE HILL RD/CROSS HILL RD , ONE TREE HILL (Grass Fire)

Source: South Australia County Fire Service

ONE TREE HILL

Issued on
29 Jan 2026 20:58

One Tree Hill Fire

The CFS is responding to a grass and scrub fire burning east of One Tree Hill, in the Adelaide Hills of South Australia.

Firefighters on approximately 9 trucks, supported by South Australian Police, are currently responding to the fire which has burnt approximately 2 hectares and will remain at the scene until the fire is fully extinguished and deemed safe.

CFS crews are working hard in windy conditions to prevent this fire spreading towards the One Tree Hill township. There is currently no threat to community from this fire.

Road closures are in place in and around the fireground for community safety, and access may be restricted until roads are deemed safe by emergency services.

Current road closures are:
– One Tree Hill Road
– Crosshill Road

For more information about road closures visit https://traffic.sa.gov.au/

To ensure your safety and that of firefighters and other emergency personnel who are working in the area, please do not enter unless necessary.

The cause of this fire is yet to be determined and Fire Investigators will attend the scene when safe.

Message ID 0009118

Posted on

Call for information – Aggravated assault – Nightcliff

Source: Northern Territory Police and Fire Services

The Northern Territory Police Force is calling for information in relation to a domestic violence incident that occurred in Nightcliff this morning.

Around 9:25am, police were conducting patrols when a 42-year-old male was located suffering a serious injury to his abdomen in a residential address on Progress Drive.

Initial investigations indicate that the victim was allegedly assaulted by a woman known to him, with an edged weapon.

The alleged offender fled the scene prior to police arrival and remains outstanding.

St John Ambulance attended the scene and conveyed the victim to Royal Darwin Hospital with non-life-threatening injuries.

Police are urging anyone with information about the incident, CCTV or dashcam from the area to make contact on 131 444.  Please quote reference NTP2600009785.  Electronic evidence can be uploaded here: https://ntpol.au.evidence.com/axon/community-request/public/ntp2600009785

Anonymous reports can be made through Crime stoppers on 1800 333 000 https://crimestoppersnt.com.au/.

If you or someone you know are experiencing difficulties due to domestic violence, support services are available, including, but not limited to, 1800RESPECT (1800737732) or Lifeline 131 114.

Posted on

ACCC decides Coles’ acquisition of a supermarket and liquor site in Kalgoorlie, WA is subject to Phase 2 review

Source: Australian Ministers for Regional Development

The ACCC has decided that Coles Group Limited’s acquisition of a lease for a supermarket and liquor store in Kalgoorlie, WA requires an in-depth assessment.

As the ACCC has not approved the acquisition in its Phase 1 assessment, it will require a Phase 2 review for the acquisition to proceed.

The acquisition of the lease relates to a development proposed for a vacant site in Kalgoorlie, WA where Coles is proposing to operate a large format supermarket and liquor store. Coles already operates one existing supermarket and three Liquorland liquor stores in Kalgoorlie.

“We consider the acquisition could substantially lessen competition for the retail supply of groceries in Kalgoorlie,” ACCC Deputy Chair Mick Keogh said.

The acquisition is likely to provide Coles with a significant market share for the retail supply of groceries in a local market where competitive constraint from rival supermarkets may be limited and timely new entry may be unlikely.

The ACCC is also considering whether the acquisition may create, strengthen or entrench Coles’ substantial market power in the local market.  

The ACCC has not reached a conclusion on the issues and will continue to consider the acquisition in Phase 2.

“We believe this acquisition needs an in-depth assessment to understand the likely impact it will have on competition in Kalgoorlie,” Mr Keogh said.

“We look forward to speaking to more industry participants and interested parties in the coming weeks.”

The ACCC invites submissions in response to its Phase 2 Notice by 13 February 2026. Parties can contact the ACCC via mergers@accc.gov.au.

It is the first acquisition that the ACCC has considered since additional targeted notification requirements were determined by the Assistant Minister for Competition that apply to acquisitions by Coles and Woolworths.

More information and the Phase 2 Notice will be available on the ACCC’s acquisitions register today here: Coles – supermarket and liquor site in Kalgoorlie, WA

Background

Coles is an Australian public company (ASX:COL) that operates supermarkets and retail liquor stores nationwide.

The lessor, M Holding 4 Pty Ltd, is an Australian private company specialising in residential and commercial property sales, management and development in Western Australia. 

Merger control regime

From 1 January 2026, it is mandatory for businesses to notify the ACCC of any acquisition that meets the notification thresholds set by the Minister. They must wait for ACCC approval before they can proceed. 

Once notified, the notification is listed on the ACCC’s Acquisitions Register and stakeholder consultation is invited. The ACCC is required to make a decision in 15 to 30 business days in its Phase 1 assessment, subject to any extensions, to either approve the acquisition or decide it is to be subject to a Phase 2 review.

The ACCC can decide a notification is to be subject to a Phase 2 review if the ACCC is satisfied that the acquisition to which the notification relates, if put into effect, could, in all of the circumstances, have the effect, or be likely to have the effect, of substantially lessening competition in any market.

Under the Competition and Consumer Act, a Phase 2 assessment can take up to 90 business days, unless extended under specific circumstances.

From 1 January 2026, there are additional targeted notification requirements on certain acquisitions by Coles and Woolworths.

This includes all acquisitions by Coles and Woolworths of supermarket businesses and all land acquisitions above certain land sizes. These acquisitions are required to be notified regardless of the general notification thresholds or control exemption.

Coles voluntarily notified this acquisition under the formal regime prior to 1 January 2026.  

More guidance on the new merger regime can be found on the ACCC’s website: Guidance documents for the merger control regime